Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,036
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling
(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, w...
US court rules against GSK in dispute with AnaptysBio
(Sharecast News) - A US court has granted a motion to dismiss filed by biotech AnaptysBio in a dispute with GSK's oncology unit, it was confirmed on M...
US military no longer required to get flu vaccine, Hegseth says
WASHINGTON, April 21 (Reuters) - The Pentagon will no longer require members of the U.S. military to get the flu vaccine, Defense Secretary Pete He...
European shares dip as US-Iran tensions weigh on sentiment
* Thales shares drop after Q1 sales miss analyst forecasts
GSK wins China approval for Blenrep for refractory multiple myeloma
(Alliance News) - GSK PLC on Monday said the National Medical Products Administration of China has approved Blenrep in combination with bortezomib and...
LONDON BRIEFING: Kainos guides revenue beat; Evoke in takeover talks
(Alliance News) - Plus500 expects 2026 earnings to beat current expectations, Advanced Medical Solutions and Evoke separately confirm takeover talks a...
GSK's Blenrep gets green light from China's NMPA
(Sharecast News) - Drugmaker GSK said on Monday that its relapsed/refractory multiple myeloma treatment Blenrep had received approval from China's Nat...
Follow the stocks
